Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 51
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL01
NCT00198991
2.
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL03
NCT00199004
3.
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
16 and over
Other
MK1-192
NCT00180128
4.
Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
60 and over
Other
AML_GT60_DD
NCT00180167
5.
Study Treatment to Low Risk ALL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 and under
Other
LAL-BR/2001
NCT00526175
6.
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
65 and under
Other
LAL-Ph-2000
NCT00526305
7.
Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
16 and under
Other
LAL-AR-N-2005
NCT00526409
8.
German Multicenter Trial for the Treatment of Newly Diagnosed T-Lymphoblastic Lymphoma in Adults
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL04
NCT00199017
Last Modified:
10/31/2008
 
First Published:
3/22/2007
9.
Phase II/III Randomized Study of Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Biomarker/Laboratory analysis, Treatment
Active
Any age
Other
UHW-AML16
EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480
Last Modified:
12/28/2008
 
First Published:
4/1/1999
10.
Phase III Randomized Study of Dexamethasone Versus Prednisolone During Induction Therapy and Prolonged Versus Conventional Duration Asparaginase During Consolidation and Late Intensification Therapy in Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 18
Other
EORTC-58951
NCT00003728
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute